Mice treated with anti-RhoA siRNA (tumor volume, 200 mm3) and anti-RhoC siRNA (tumor volume, 600 mm3) showed less tumor growth than in the control group (1300 mm3). This evidence concerns the gene RHOC and neoplasm.